According to Bloomberg, Frazier SPAC (FLAC) Is in Talks to Merge With NewAmsterdam Pharma

October 14, 2022

NewAmsterdam Pharma BV, a biotechnology company that aims to treat metabolic diseases, is in talks to go public through a merger with blank-check firm Frazier Lifesciences Acquisition Corp. (FLAC), according to people with knowledge of the matter.

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe Today

According to Bloomberg, Frazier SPAC (FLAC) Is in Talks to Merge With NewAmsterdam Pharma

Prev Post

According to Bloomberg, LAMF Global Ventures Corp. I (LGVC) in talks with Everton FC

Next Post

Looking for more premium content?